Brief: Spyre Therapeutics Appoints Dr. Sandra Milligan to Board of Directors
15/05/2024 12:38
May 15 (Reuters) - Spyre Therapeutics Inc SYRE.O :
* SPYRE THERAPEUTICS APPOINTS ACCOMPLISHED BIOPHARMA LEADER
DR.
SANDRA MILLIGAN TO ITS BOARD OF DIRECTORS
Source text for Eikon: ID:nPn81hxmPa
Further company coverage: SYRE.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Spyre Therapeutics
See all newsU.S. STOCKS ON THE MOVE-Becton Dickinson, Constellation Energy, Marvell
U.S. STOCKS ON THE MOVE-Constellation Energy, AMD
U.S. STOCKS ON THE MOVE-MYR Group, Spyre Therapeutics, AMD
Spyre Therapeutics slips on $350 mln share sale
Brief: Spyre Therapeutics Announces Pricing Of $350.0 Million Public Offering Of Common Stock